Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.4638
+0.0138 (3.07%)
Aug 3, 2026, 11:23 AM EDT - Market open
Traws Pharma Employees
As of December 31, 2025, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$390,429
Profits / Employee
-$1,987,143
Market Cap
7.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 4 | 3 |
| Dec 31, 2024 | 7 | -11 | -61.11% | 6 | 1 |
| Dec 31, 2023 | 18 | 1 | 5.88% | 17 | 1 |
| Dec 31, 2022 | 17 | 2 | 13.33% | 16 | 1 |
| Dec 31, 2021 | 15 | 3 | 25.00% | 14 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 20 |
| MetaVia | 8 |
| Alzamend Neuro | 6 |
| Adial Pharmaceuticals | 5 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
| Kairos Pharma | 4 |
| Acurx Pharmaceuticals | 4 |
TRAW News
- 26 days ago - Traws Pharma Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Traws Pharma files $139.19M mixed securities shelf - TheFly
- 4 weeks ago - Traws Pharma Registration statement: Registration filing - Filings
- 6 weeks ago - Traws Pharma provides update on tivoxavir marboxil program - TheFly
- 6 weeks ago - Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program - GlobeNewsWire
- 6 weeks ago - Traws Pharma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 7 weeks ago - Traws Pharma downgraded to Neutral from Buy at Ladenburg - TheFly
- 7 weeks ago - Traws Pharma influenza challenge study deferred following MHRA review - TheFly